Published 9 days ago • loading... • Updated 9 days ago

Mitigating Barriers to Cell and Gene Therapy Access

Summary by ajmc.com

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

ajmc.com

Mitigating Barriers to Cell and Gene Therapy Access

9 days ago

Read Full Article

Express Pharma

Evolution and commercialisation of cell and gene therapies - Express Pharma

The field of cell and gene therapy has experienced remarkable progress since the early 2000s. A pivotal milestone was the USFDA’s approval of Carticel by Genzyme in 1997, marking the first cell therapy approved in the U.S. for the treatment of cartilage defects in the knee. This groundbreaking achievement paved the way for the development of autologous cell therapies targeting multiple medical conditions. As of 2024, there are over 68 non-geneti…

9 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right